--- title: "Inogen (INGN) stock listing, news and investor profile" url: "https://aibio.space/companies/inogen/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Inogen Inc (NASDAQ: INGN), United States. Listing facts, related biotech companies and news on aibio.space." --- INGN Inogen Inc NASDAQ · United States # Inogen (INGN) news Inogen Inc is a public biotech or pharmaceutical company listed on NASDAQ under the ticker INGN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Inogen news We have not published a story on Inogen yet. When there is news, it will appear here. ## Inogen at a glance - **Ticker**: INGN - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $105.5 million ### Related companies - [Harvard Apparatus Regenerative Technology](https://aibio.space/companies/harvard-apparatus-regenerative-technology/) OTC: HRGN - [NIKA PHARMACEUTICALS, INC](https://aibio.space/companies/nika-pharmaceuticals/) OTC: NIKA - [INTELLIGENT BIO SOLUTIONS INC.](https://aibio.space/companies/intelligent-bio-solutions/) NASDAQ: INBS - [National Vision Holdings](https://aibio.space/companies/national-vision/) NASDAQ: EYE - [ENvue Medical](https://aibio.space/companies/envue-medical/) OTC: FEED - [CARLSMED, INC.](https://aibio.space/companies/carlsmed/) NASDAQ: CARL - [Cresco Labs](https://aibio.space/companies/cresco-labs/) OTC: CRLBF - [Aclarion](https://aibio.space/companies/aclarion/) NASDAQ: ACON ### Also on NASDAQ - [AgomAb Therapeutics NV](https://aibio.space/companies/agomab-therapeutics/) AGMB - [NRC HEALTH](https://aibio.space/companies/nrc-health/) NRC - [Virax Biolabs Group](https://aibio.space/companies/virax-biolabs/) VRAX - [Seer](https://aibio.space/companies/seer/) SEER - [Acumen Pharmaceuticals](https://aibio.space/companies/acumen-pharmaceuticals/) ABOS - [Alector](https://aibio.space/companies/alector/) ALEC ## Inogen annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$348.7 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | [$335.7 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | | Research and development | [$19.4 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | [$21.6 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | | Net income (loss) | [-$22.7 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | [-$35.9 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | | Cash from operations | [-$11.2 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | [$5.9 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | | Cash and equivalents | [$103.7 million](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000034/) | [$113.8 million](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | | Short-term investments | [$15.8 million](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000034/) | [$0](https://www.sec.gov/Archives/edgar/data/1294133/000119312526082630/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $87.3 million, plus short-term investments of $18.3 million, $105.5 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Inogen What is the ticker symbol of Inogen? Inogen Inc trades under the ticker INGN on NASDAQ. Where is Inogen listed? Inogen Inc is listed on NASDAQ. Which country or territory is Inogen listed under? Our directory records Inogen Inc under United States. Does aibio.space cover Inogen? aibio.space lists Inogen Inc among 2,820 public biotech companies and publishes its news here as stories appear. What was Inogen's revenue last year? $348.7 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Inogen profitable? Inogen Inc reported a net loss of $22.7 million for the fiscal year ended Dec 31, 2025, and used $11.2 million of cash in operations, per its annual report to the SEC. How much does Inogen spend on research and development? $19.4 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Inogen have? $105.5 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: Inogen Members talk about Inogen (INGN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Inogen, newest first. Each line links the filing it comes from. 1. 2026-09-30 Financings Announced a share repurchase program. SEC Form 8-K (Items 1.01,7.01,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000037/ingn-ex99_1.htm) 2. 2026-07-01 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 5.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/ingn-ex99_1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:INGN on TradingView](https://www.tradingview.com/symbols/NASDAQ-INGN/). ## Listing details Inogen Inc is a public biotech or pharmaceutical company listed on NASDAQ under the ticker INGN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Inogen Inc - **Ticker**: INGN - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/inogen/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Inogen (INGN) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/inogen/